glp-1 companies list 2.0: Where the Next Wave of Value Will Be Created GLP-1 Medications: Everything You Need

Quarenghi, M., Capelli, S., Galligani, G., Giana, A., Preatoni, G., & Turri Quarenghi, R

Shima Hadidchi, MD and her team offer exceptional care for patients considering oral semaglutide and other advanced weight-loss treatments: 1

faced a shortage of semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (the active ingredient in Eli Lillys weight-loss drug Zepbound and its diabetes drug Mounjaro)

Crane et al

Plaintiffs contend that Eli Lilly did not provide adequate warnings about the potential severity and persistence of these complications, while the manufacturer disputes causation and raises case-specific defenses